These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 36116508)

  • 1. EGFR Signaling Is Overactive in Pachyonychia Congenita: Effective Treatment with Oral Erlotinib.
    Basset J; Marchal L; Hovnanian A
    J Invest Dermatol; 2023 Feb; 143(2):294-304.e8. PubMed ID: 36116508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pachyonychia congenita in pediatric patients: natural history, features, and impact.
    Shah S; Boen M; Kenner-Bell B; Schwartz M; Rademaker A; Paller AS
    JAMA Dermatol; 2014 Feb; 150(2):146-53. PubMed ID: 24132595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin selectively inhibits expression of an inducible keratin (K6a) in human keratinocytes and improves symptoms in pachyonychia congenita patients.
    Hickerson RP; Leake D; Pho LN; Leachman SA; Kaspar RL
    J Dermatol Sci; 2009 Nov; 56(2):82-8. PubMed ID: 19699613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new KRT16 mutation associated with a phenotype of pachyonychia congenita.
    Paris F; Hurtado C; Azón A; Aguado L; Vizmanos JL
    Exp Dermatol; 2013 Dec; 22(12):838-9. PubMed ID: 24118415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene expression profiling in pachyonychia congenita skin.
    Cao YA; Hickerson RP; Seegmiller BL; Grapov D; Gross MM; Bessette MR; Phinney BS; Flores MA; Speaker TJ; Vermeulen A; Bravo AA; Bruckner AL; Milstone LM; Schwartz ME; Rice RH; Kaspar RL
    J Dermatol Sci; 2015 Mar; 77(3):156-65. PubMed ID: 25656049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pachyonychia congenita: a case report of a successful treatment with rosuvastatin in a patient with a KRT6A mutation.
    Abdollahimajd F; Rajabi F; Shahidi-Dadras M; Saket S; Youssefian L; Vahidnezhad H; Uitto J
    Br J Dermatol; 2019 Sep; 181(3):584-586. PubMed ID: 30307612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The phenotypic and molecular genetic features of pachyonychia congenita.
    McLean WH; Hansen CD; Eliason MJ; Smith FJ
    J Invest Dermatol; 2011 May; 131(5):1015-7. PubMed ID: 21430705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A spectrum of mutations in keratins K6a, K16 and K17 causing pachyonychia congenita.
    Liao H; Sayers JM; Wilson NJ; Irvine AD; Mellerio JE; Baselga E; Bayliss SJ; Uliana V; Fimiani M; Lane EB; McLean WH; Leachman SA; Smith FJ
    J Dermatol Sci; 2007 Dec; 48(3):199-205. PubMed ID: 17719747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First case of pachyonychia congenita in the Czech Republic.
    Jiráková A; Rajská L; Rob F; Džambová M; Sečníková Z; Göpfertová D; Schwartz M; Smith F; Lotti T; Hercogová J
    Dermatol Ther; 2015; 28(1):10-2. PubMed ID: 25174302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathophysiology of pachyonychia congenita-associated palmoplantar keratoderma: new insights into skin epithelial homeostasis and avenues for treatment.
    Zieman AG; Coulombe PA
    Br J Dermatol; 2020 Mar; 182(3):564-573. PubMed ID: 31021398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype‒Structurotype‒Phenotype Correlations in Patients with Pachyonychia Congenita.
    Wu TT; Eldirany SA; Bunick CG; Teng JMC
    J Invest Dermatol; 2021 Dec; 141(12):2876-2884.e4. PubMed ID: 34116063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic profiling reveals KRT6C as a probable hereterodimer partner for KRT9: New insights into re-classifying epidermolytic palmoplantar keratoderma (EPPK) and a milder form of pachyonychia congenita (PC-K6c) as a group of genetic cutaneous disorders.
    Li P; Qi J; Zhong Y; Ding A; Xiao H
    J Proteomics; 2023 Sep; 287():104971. PubMed ID: 37467889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of Epidermal Growth Factor Receptor Inhibitor Erlotinib to Treat Palmoplantar Keratoderma in Patients With Olmsted Syndrome Caused by TRPV3 Mutations.
    Greco C; Leclerc-Mercier S; Chaumon S; Doz F; Hadj-Rabia S; Molina T; Boucheix C; Bodemer C
    JAMA Dermatol; 2020 Feb; 156(2):191-195. PubMed ID: 31895432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Painful Palmoplantar Keratoderma Related to Pachyonychia Congenita Using EGFR Inhibitors.
    Greco C; Ponsen AC; Leclerc-Mercier S; Schlatter J; Cisternino S; Boucheix C; Bodemer C
    Biomedicines; 2022 Apr; 10(4):. PubMed ID: 35453591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two for two: Dual therapy with erlotinib and acitretin for twins with severe keratoderma in Olmsted syndrome.
    Butala S; Phan S; Siegel DH; Carlberg V; Paller AS
    Pediatr Dermatol; 2023; 40(4):735-737. PubMed ID: 36709954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revisiting pachyonychia congenita: a case-cohort study of 815 patients.
    Samuelov L; Smith FJD; Hansen CD; Sprecher E
    Br J Dermatol; 2020 Mar; 182(3):738-746. PubMed ID: 31823354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pachyonychia congenita. Keratin gene mutations with pleiotropic effect].
    Swensson O
    Hautarzt; 1999 Jul; 50(7):483-90. PubMed ID: 10464680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can skin disease cause neuropathic pain? A study in pachyonychia congenita.
    Wallis T; Poole CD; Hoggart B
    Clin Exp Dermatol; 2016 Jan; 41(1):26-33. PubMed ID: 26358843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel and recurrent mutations in the genes encoding keratins K6a, K16 and K17 in 13 cases of pachyonychia congenita.
    Terrinoni A; Smith FJ; Didona B; Canzona F; Paradisi M; Huber M; Hohl D; David A; Verloes A; Leigh IM; Munro CS; Melino G; McLean WH
    J Invest Dermatol; 2001 Dec; 117(6):1391-6. PubMed ID: 11886499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of botulinum toxin in pachyonychia congenita type 1: report of two new cases.
    González-Ramos J; Sendagorta-Cudós E; González-López G; Mayor-Ibarguren A; Feltes-Ochoa R; Herranz-Pinto P
    Dermatol Ther; 2016; 29(1):32-6. PubMed ID: 26445325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.